Limbal squamous cell carcinoma in a Rocky Mountain Horse: Case report and investigation of genetic contribution

Kelly E. Knickelbein, Mary Utter, Rebecca Bellone

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To document a case of limbal squamous cell carcinoma (SCC) in a Rocky Mountain Horse stallion determined to be homozygous for the genetic risk factor (DDB2 c.1013C>T) strongly associated with the disease in Haflinger and Belgian horses, and to determine the frequency of this allele in a larger population of Rocky Mountain Horses. Animals studied: One privately owned Rocky Mountain Horse and 84 Rocky Mountain Horses screened for allelic frequency. Procedures: A complete ophthalmic examination was performed on a Rocky Mountain Horse stallion for assessment of a mass affecting the right eye. A clinical diagnosis of suspected limbal SCC was made, and routine keratoconjunctivectomy and adjunctive strontium irradiation were performed. Genotyping for the DDB2 c.1013C > T (rs1139682898) risk variant was performed utilizing an allele-specific PCR assay on DNA isolated from whole blood and hair follicles. Results: Histopathology confirmed the limbal mass to be consistent with SCC. The horse was genotyped as homozygous for the DDB2 c.1013C >T risk variant. The frequency of the variant allele among a population of 84 Rocky Mountain Horses was found to be 0.20. Conclusion: The Rocky Mountain Horse breed possesses the DDB2 variant allele determined to be a significant risk factor for ocular SCC in the Haflinger and Belgian breeds. Genotyping additional Rocky Mountain Horses diagnosed with ocular SCC as well as confirmed healthy controls for this variant should be undertaken to determine whether a significant association exists between ocular SCC and the variant in the Rocky Mountain Horse breed.

Original languageEnglish (US)
JournalVeterinary Ophthalmology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

squamous cell carcinoma
Horses
Squamous Cell Carcinoma
case studies
eyes
Belgian (horse breed)
horse breeds
stallions
alleles
genotyping
gene frequency
Gene Frequency
risk factors
Rocky Mountain Horse
horses
Alleles
hair follicles
strontium
Strontium
Hair Follicle

Keywords

  • cancer
  • damage-specific DNA binding protein 2 (DDB2)
  • equine
  • genetics
  • ocular

ASJC Scopus subject areas

  • veterinary(all)

Cite this

@article{f341dbd5b52c44cc91d2dcb640ff6339,
title = "Limbal squamous cell carcinoma in a Rocky Mountain Horse: Case report and investigation of genetic contribution",
abstract = "Objective: To document a case of limbal squamous cell carcinoma (SCC) in a Rocky Mountain Horse stallion determined to be homozygous for the genetic risk factor (DDB2 c.1013C>T) strongly associated with the disease in Haflinger and Belgian horses, and to determine the frequency of this allele in a larger population of Rocky Mountain Horses. Animals studied: One privately owned Rocky Mountain Horse and 84 Rocky Mountain Horses screened for allelic frequency. Procedures: A complete ophthalmic examination was performed on a Rocky Mountain Horse stallion for assessment of a mass affecting the right eye. A clinical diagnosis of suspected limbal SCC was made, and routine keratoconjunctivectomy and adjunctive strontium irradiation were performed. Genotyping for the DDB2 c.1013C > T (rs1139682898) risk variant was performed utilizing an allele-specific PCR assay on DNA isolated from whole blood and hair follicles. Results: Histopathology confirmed the limbal mass to be consistent with SCC. The horse was genotyped as homozygous for the DDB2 c.1013C >T risk variant. The frequency of the variant allele among a population of 84 Rocky Mountain Horses was found to be 0.20. Conclusion: The Rocky Mountain Horse breed possesses the DDB2 variant allele determined to be a significant risk factor for ocular SCC in the Haflinger and Belgian breeds. Genotyping additional Rocky Mountain Horses diagnosed with ocular SCC as well as confirmed healthy controls for this variant should be undertaken to determine whether a significant association exists between ocular SCC and the variant in the Rocky Mountain Horse breed.",
keywords = "cancer, damage-specific DNA binding protein 2 (DDB2), equine, genetics, ocular",
author = "Knickelbein, {Kelly E.} and Mary Utter and Rebecca Bellone",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/vop.12612",
language = "English (US)",
journal = "Veterinary Ophthalmology",
issn = "1463-5216",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Limbal squamous cell carcinoma in a Rocky Mountain Horse

T2 - Case report and investigation of genetic contribution

AU - Knickelbein, Kelly E.

AU - Utter, Mary

AU - Bellone, Rebecca

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: To document a case of limbal squamous cell carcinoma (SCC) in a Rocky Mountain Horse stallion determined to be homozygous for the genetic risk factor (DDB2 c.1013C>T) strongly associated with the disease in Haflinger and Belgian horses, and to determine the frequency of this allele in a larger population of Rocky Mountain Horses. Animals studied: One privately owned Rocky Mountain Horse and 84 Rocky Mountain Horses screened for allelic frequency. Procedures: A complete ophthalmic examination was performed on a Rocky Mountain Horse stallion for assessment of a mass affecting the right eye. A clinical diagnosis of suspected limbal SCC was made, and routine keratoconjunctivectomy and adjunctive strontium irradiation were performed. Genotyping for the DDB2 c.1013C > T (rs1139682898) risk variant was performed utilizing an allele-specific PCR assay on DNA isolated from whole blood and hair follicles. Results: Histopathology confirmed the limbal mass to be consistent with SCC. The horse was genotyped as homozygous for the DDB2 c.1013C >T risk variant. The frequency of the variant allele among a population of 84 Rocky Mountain Horses was found to be 0.20. Conclusion: The Rocky Mountain Horse breed possesses the DDB2 variant allele determined to be a significant risk factor for ocular SCC in the Haflinger and Belgian breeds. Genotyping additional Rocky Mountain Horses diagnosed with ocular SCC as well as confirmed healthy controls for this variant should be undertaken to determine whether a significant association exists between ocular SCC and the variant in the Rocky Mountain Horse breed.

AB - Objective: To document a case of limbal squamous cell carcinoma (SCC) in a Rocky Mountain Horse stallion determined to be homozygous for the genetic risk factor (DDB2 c.1013C>T) strongly associated with the disease in Haflinger and Belgian horses, and to determine the frequency of this allele in a larger population of Rocky Mountain Horses. Animals studied: One privately owned Rocky Mountain Horse and 84 Rocky Mountain Horses screened for allelic frequency. Procedures: A complete ophthalmic examination was performed on a Rocky Mountain Horse stallion for assessment of a mass affecting the right eye. A clinical diagnosis of suspected limbal SCC was made, and routine keratoconjunctivectomy and adjunctive strontium irradiation were performed. Genotyping for the DDB2 c.1013C > T (rs1139682898) risk variant was performed utilizing an allele-specific PCR assay on DNA isolated from whole blood and hair follicles. Results: Histopathology confirmed the limbal mass to be consistent with SCC. The horse was genotyped as homozygous for the DDB2 c.1013C >T risk variant. The frequency of the variant allele among a population of 84 Rocky Mountain Horses was found to be 0.20. Conclusion: The Rocky Mountain Horse breed possesses the DDB2 variant allele determined to be a significant risk factor for ocular SCC in the Haflinger and Belgian breeds. Genotyping additional Rocky Mountain Horses diagnosed with ocular SCC as well as confirmed healthy controls for this variant should be undertaken to determine whether a significant association exists between ocular SCC and the variant in the Rocky Mountain Horse breed.

KW - cancer

KW - damage-specific DNA binding protein 2 (DDB2)

KW - equine

KW - genetics

KW - ocular

UR - http://www.scopus.com/inward/record.url?scp=85053493960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053493960&partnerID=8YFLogxK

U2 - 10.1111/vop.12612

DO - 10.1111/vop.12612

M3 - Article

C2 - 30238589

AN - SCOPUS:85053493960

JO - Veterinary Ophthalmology

JF - Veterinary Ophthalmology

SN - 1463-5216

ER -